HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Walczak Selected Research

H Walczak Research Topics

Disease

15Neoplasms (Cancer)
12/2019 - 06/2000
7Necrosis
11/2014 - 04/2000
3Melanoma (Melanoma, Malignant)
07/2013 - 05/2008
2Head and Neck Neoplasms (Head and Neck Cancer)
11/2014 - 10/2014
2Squamous Cell Carcinoma of Head and Neck
11/2014 - 10/2014
2Inflammation (Inflammations)
11/2014 - 11/2013
2Hepatocellular Carcinoma (Hepatoma)
11/2014 - 07/2004
2Infections
06/2013 - 12/2001
2Glioma (Gliomas)
02/2008 - 07/2001
1Hepatitis
11/2014
1Chronic Hepatitis (Chronic Active Hepatitis)
11/2014
1Liver Diseases (Liver Disease)
11/2014
1Liver Failure
11/2014
1Lung Neoplasms (Lung Cancer)
03/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014
1Reperfusion Injury
11/2013
1Human Influenza (Influenza)
06/2013
1Carcinoma (Carcinomatosis)
04/2008
1Glioblastoma (Glioblastoma Multiforme)
02/2008
1Lymphoma (Lymphomas)
03/2002
1Adenocarcinoma
07/2001
1Renal Cell Carcinoma (Grawitz Tumor)
11/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2000
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2000

Drug/Important Bio-Agent (IBA)

10LigandsIBA
11/2014 - 06/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2014 - 06/2000
6Caspase 8 (Caspase-8)IBA
11/2014 - 01/2000
5Death Domain ReceptorsIBA
05/2016 - 01/2000
5Proteins (Proteins, Gene)FDA Link
11/2014 - 02/2008
5TNF-Related Apoptosis-Inducing LigandIBA
09/2014 - 04/2000
4Fas Ligand Protein (Fas Ligand)IBA
05/2008 - 07/2001
3Pharmaceutical PreparationsIBA
07/2013 - 06/2000
3NF-kappa B (NF-kB)IBA
11/2008 - 04/2000
2Interleukin-4 (Interleukin 4)IBA
12/2019 - 04/2008
2Antineoplastic Agents (Antineoplastics)IBA
11/2014 - 10/2014
2Phosphotransferases (Kinase)IBA
11/2014 - 02/2008
2CaspasesIBA
10/2014 - 06/2010
2Bortezomib (Velcade)FDA Link
10/2014 - 06/2010
1Caspase 10IBA
11/2014
1BH3 Interacting Domain Death Agonist ProteinIBA
11/2014
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2014
1Cyclin-Dependent Kinase 9IBA
03/2014
1N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
03/2014
1Cisplatin (Platino)FDA LinkGeneric
07/2013
1Poly I-CIBA
06/2013
1Toll-Like Receptor 3IBA
06/2013
1Small Interfering RNA (siRNA)IBA
02/2008
1Glucose (Dextrose)FDA LinkGeneric
02/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
01/2008
1Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA
02/2007
1factor AIBA
02/2007
1butyl phosphorotrithioate (DEF)IBA
02/2007
1SuperantigensIBA
03/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2002
1AntigensIBA
03/2002
1Antiviral Agents (Antivirals)IBA
12/2001
1Protein Kinase CIBA
07/2001
1Lomustine (CCNU)FDA Link
07/2001
1Cytochromes c (Cytochrome c)IBA
07/2001
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
07/2001
1Topotecan (Hycamtin)FDA LinkGeneric
11/2000
1Etoposide (VP 16)FDA LinkGeneric
06/2000
1CytokinesIBA
04/2000
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
02/2000

Therapy/Procedure

8Therapeutics
05/2016 - 04/2001
4Drug Therapy (Chemotherapy)
10/2014 - 06/2000
1Transplantation
11/2013
1Chemoradiotherapy
07/2001
1Aftercare (After-Treatment)
02/2000